Captopril Completed Phase 1 Trials for Pulmonary Hypertension (PH) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00240656Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension